Nonsteroidal antiinflammatory drugs suppress pain-related behaviors, but not referred hyperalgesia of visceral pain in mice

Anesthesia and Analgesia

Volumn 102, Issue 1, 2006, Pages 195-200

  Shin, Jin Woo ^a   Hwang, Kyu Sam ^a   Kim, Yoo Kyung ^a   Leem, Jeong Gill ^a,b   Lee, Cheong ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 FLUOROPHENYL) 4 (4 METHYLSULFONYLPHENYL) 5,5 DIMETHYL 5H FURAN 2 ONE; ALCOHOL; ALLYL ISOTHIOCYANATE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DIMETHYL SULFOXIDE; EVANS BLUE; KETOPROFEN; KETOROLAC; KETOROLAC TROMETAMOL; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLON; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXTRAVASATION; HYPERALGESIA; MALE; MOUSE; NONHUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; REFERRED PAIN; SCORING SYSTEM; TISSUE LEVEL; VISCERAL PAIN; WITHDRAWAL REFLEX;

EID: 29844431895     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000184828.39754.a3     Document Type: Article

References (23)

1. Cervero F. Visceral pain: mechanisms of peripheral and central sensitization. Ann Med 1995;27:235-9.
2. Cervero F, Janig W. Visceral nociceptors: a new world order? Trends Neurosci 1992;15:374-8.
3. Giamberardino MA. Recent and forgotten aspects of visceral pain. Eur J Pain 1999;3:77-92.
4. Cervero F. Visceral hyperalgesia revisited. Lancet 2000;356:1127-8.
5. Ness TJ, Gebhart GF. Visceral pain: a review of experimental studies. Pain 1990;41:167-234.
6. Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain 2001;92:335-42.
7. Gordon SM, Brahim JS, Rowan J, et al. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. Clin Pharmacol Ther 2002;72:175-83.
8. Ghilardi JR, Svensson CI, Rogers SD, et al. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J Neurosci 2004;24:2727-32.
9. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-82.
10. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-60.
11. Miranda HF, Sierralta F, Pinardi G. Neostigmine interactions with non steroidal anti-inflammatory drugs. Br J Pharmacol 2002;135:1591-7.
12. Domer F. Characterization of the analgesic activity of ketorolac in mice. Eur J Pharmacol 1990;177:127-35.
13. Grond S, Demopulos G, Herz J, Pierce-Palmer P. Inhibition of synovial plasma extravasation by preemptive administration of an anti-inflammatory irrigation solution in the rat knee. Anesth Analg 2001;92:1301-6.
14. Xie G, Wang Y, Sharma M, et al. 5-Hydroxytryptamine-induced plasma extravasation in the rat knee joint is mediated by multiple prostaglandins. Inflamm Res 2003;52:32-8.
15. Dogrul A, Yesilyurt O, Deniz G, Isimer A. Analgesic effects of amlodipine and its interaction with morphine and ketorolac-induced analgesia. Gen Pharmacol 1997;29:839-45.
16. McMahon SB. Mechanisms of cutaneous, deep and visceral pain. In: Wall PD, Melzack R, eds. Textbook of pain, 3rd ed. Edinburgh: Churchill Livingstone, 1994:129-32.
17. Shin SW, Sandner-Kiesling A, Eisenach JC. Systemic, but not intrathecal ketorolac is antinociceptive to uterine cervical distension in rats. Pain 2003;105:109-14.
18. Simons DG, Travell JG, Simons LS. Myofascial pain and dysfunction: the trigger point manual. 2nd ed. Baltimore: Lippincott Williams & Wilkins, 1999:57-63.
19. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001;294:1871-5.
20. Ibuki T, Matsumura K, Yamazaki Y, et al. Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia. J Neurochem 2003;86:318-28.
21. Miranda HF, Sierralta F, Pinardi G. Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice. Anesth Analg 1993;77:750-3.
22. Tripathi A, Welch SP. Blockade of the antinociceptive activity of centrally administered ketorolac by nor-binaltorphimine. Eur J Pharmacol 1995;278:27-32.
23. Sotgiu ML, Biella G, Formaglio F, Marchettini P. Central effect of ketorolac involving NMDA receptors activity. Brain Res 1998;813:223-6.